Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.

Marquita CamilleriThomas McGrathWilliam WilsonStuart J IngsJacqueline HorderFiona NewrickJonathan SiveXenofon PapanikolaouRakesh PopatCharalampia KyriakouKwee L YongNeil Rabin

Published in: Leukemia & lymphoma (2021)

Keyphrases

stem cells
peripheral blood
newly diagnosed
end stage renal disease
coronavirus disease
ejection fraction
sars cov
chronic kidney disease
peritoneal dialysis
bone marrow
mesenchymal stem cells
multiple myeloma
patient reported